Lovastatin

GPTKB entity

Statements (45)
Predicate Object
gptkbp:instanceOf statin
cholesterol-lowering drug
gptkbp:approvalYear 1987
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode C10AA02
gptkbp:bioavailability less than 5%
gptkbp:brand gptkb:Altocor
gptkb:Mevacor
gptkbp:CASNumber 75330-75-5
gptkbp:category lactone
prodrug
fungal metabolite
lipid-lowering agent
gptkbp:chemicalFormula C24H36O5
gptkbp:contraindication gptkb:liver_disease
pregnancy
gptkbp:discoveredBy gptkb:Akira_Endo
gptkbp:drugInteraction gptkb:milk
gptkb:erythromycin
itraconazole
gptkbp:eliminationHalfLife 2-5 hours
https://www.w3.org/2000/01/rdf-schema#label Lovastatin
gptkbp:IUPACName (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
gptkbp:KEGGID D00348
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:United_States
gptkbp:mechanismOfAction HMG-CoA reductase inhibitor
gptkbp:meltingPoint 174-178°C
gptkbp:metabolism liver
gptkbp:molecularWeight 404.55 g/mol
gptkbp:origin fermentation of Aspergillus terreus
gptkbp:patentExpired 2001
gptkbp:PubChem_CID 53232
DB00227
CHEMBL44632
gptkbp:routeOfAdministration oral
gptkbp:sideEffect muscle pain
rhabdomyolysis
liver enzyme elevation
gptkbp:UNII BKJ8M8G8AP
gptkbp:usedFor gptkb:familial_hypercholesterolemia
prevention of cardiovascular disease
gptkbp:bfsParent gptkb:C10AA
gptkb:Statins
gptkbp:bfsLayer 7